Respiri, an eHealth SaaS company specialising in respiratory health management and remote patient monitoring, secured $1.6 million in funding through an additional placement to existing sophisticated shareholders.
The capital raise aims to fuel the company's remote patient monitoring business growth in the US.
Funds will be allocated towards finalising the acquisition of Access Managed Services and bolstering working capital for expansion efforts.
Respiri's wheezo technology enhances asthma management by monitoring wheezing and facilitating data sharing with healthcare professionals.